Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.560 | 3.220 | 0.660 |
Stocks | 97.430 | 97.430 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.450 | 16.361 |
Price to Book | 2.374 | 2.707 |
Price to Sales | 1.573 | 2.073 |
Price to Cash Flow | 13.072 | 10.453 |
Dividend Yield | 2.169 | 2.718 |
5 Years Earnings Growth | 10.830 | 12.953 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 49.220 | 13.027 |
Financial Services | 26.150 | 19.188 |
Consumer Cyclical | 19.290 | 12.579 |
Real Estate | 2.190 | 4.474 |
Consumer Defensive | 2.110 | 8.506 |
Industrials | 1.040 | 13.981 |
Number of long holdings: 56
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
IQVIA Holdings | US46266C1053 | 3.49 | 201.52 | +0.14% | |
UnitedHealth | US91324P1021 | 3.48 | 608.31 | +0.25% | |
Manulife Financial | CA56501R1064 | 3.35 | 31.78 | -0.22% | |
SCI | US8175651046 | 3.11 | 88.81 | +0.59% | |
Thermo Fisher Scientific | US8835561023 | 3.05 | 524.85 | +2.31% | |
AstraZeneca | GB0009895292 | 2.99 | 10,532.0 | +0.38% | |
Merck&Co | US58933Y1055 | 2.82 | 102.97 | +1.33% | |
Halozyme | US40637H1095 | 2.75 | 48.42 | +1.32% | |
Amundi | FR0004125920 | 2.73 | 59.80 | -0.58% | |
ResMed | US7611521078 | 2.65 | 247.93 | -0.83% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LGeneration Global EUR I | 1.82B | 11.74 | 2.22 | 12.61 | ||
LGeneration Global EUR I Dist | 1.82B | 11.74 | 2.22 | 12.71 | ||
LGeneration Global EUR M A | 1.82B | 11.55 | 2.01 | 12.43 | ||
LGeneration Global EUR M D | 1.82B | 11.55 | 2.01 | 12.44 | ||
LGeneration Global EUR P A | 1.82B | 11.18 | 1.61 | 12.17 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review